These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2041411)

  • 1. [Can cholesterol lowering treatment have unwanted effects?].
    Karpe F; Regnström J; Tornvall P
    Lakartidningen; 1991 May; 88(18):1670-1. PubMed ID: 2041411
    [No Abstract]   [Full Text] [Related]  

  • 2. Report on a double-blind investigation into the influence of -pyridyl-carbinol on the cholesterol level of the blood.
    Nelemans FA
    Arzneimittelforschung; 1972 Aug; 22(8):1410-3. PubMed ID: 4564745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of hypercholesterolemia].
    Schwandt P; Richter WO
    Wien Klin Wochenschr; 1995; 107(18):544-8. PubMed ID: 7483641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Large scale treatment? Limited knowledge about cholesterol and arteriosclerosis].
    Berglund G
    Lakartidningen; 1991 May; 88(19):1762, 1764-5, 1767. PubMed ID: 2041423
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cholesterol values of an elderly person].
    Viikari J
    Duodecim; 2002; 118(3):217-9. PubMed ID: 12233021
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholesterol lowering and morbidity and mortality.
    LaRosa JC
    Curr Opin Lipidol; 1995 Feb; 6(1):62-5. PubMed ID: 7735718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heartsick America.
    Cowley G
    Newsweek; 2001 May; 137(22):43. PubMed ID: 11393041
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lowering cholesterol. New concepts with atorvastatin].
    Internist (Berl); 1997 Jan; 38(1 Suppl):1-8. PubMed ID: 9102396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypercholesterolemia in old age--to treat or not?].
    Leiss O; Wollenweber J
    Dtsch Med Wochenschr; 1992 Jun; 117(23):912-8. PubMed ID: 1597120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increased autoaggression caused by cholesterol lowering drugs?].
    Richter WO
    Fortschr Med; 1994 Dec; 112(35-36):507-8. PubMed ID: 7843681
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hypercholesterolemia--lower is not better].
    Ravnskov U
    Ugeskr Laeger; 2006 Apr; 168(17):1665. PubMed ID: 16674887
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cholesterol lowering--Quo vadis? WOS (West of Scotland)--study of pravastin--a milestone in the prevention of myocardial infarct?!].
    Fortschr Med Suppl; 1995; 170():1-7. PubMed ID: 9022407
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
    Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for high blood cholesterol. U.S. Preventive Services Task Force.
    Am Fam Physician; 1990 Feb; 41(2):503-13. PubMed ID: 2405605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercholesterolemia in ExHC rats and lipid-lowering drug: a screening method for new hypocholesterolemic agents.
    Kitazaki T; Tsuda M; Matsumura H; Ohtagaki T; Imai Y
    Artery; 1981; 9(6):414-24. PubMed ID: 6802106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve damage rare but possible with cholesterol-lowering drugs.
    Harv Heart Lett; 2002 Aug; 12(12):8. PubMed ID: 12217847
    [No Abstract]   [Full Text] [Related]  

  • 19. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial.
    Bokura H; Kobayashi S
    Eur J Clin Nutr; 2003 May; 57(5):721-5. PubMed ID: 12771974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.